Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

16 juil. 2025 09h00 HE | Source: Cyclacel Pharmaceuticals, Inc.

CYCLACEL PHARMACEUTICALS COMMENTS ON RECENT STOCK PRICE VOLATILITY

Kuala Lumpur, Malaysia, July 16, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative...
11 avr. 2024 10h30 HE | Source: Canadian Health Policy Institute Inc.

Waiting for new medicines in Canada, Europe, and the United States: Study finds Americans get better and faster access to innovative drugs

Americans get better and faster access to innovative medicines compared to Europeans and Canadians.
11 avr. 2024 10h00 HE | Source: Canadian Health Policy Institute Inc.

Access to new medicines in Canada, Europe, and the United States: Study finds less availability and longer waits for Canadian patients

A recent study published by the Canadian Health Policy Institute examined the availability and wait times for access to new drugs.